vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and PHOTRONICS INC (PLAB). Click either name above to swap in a different company.
PHOTRONICS INC is the larger business by last-quarter revenue ($210.4M vs $123.8M, roughly 1.7× NATURES SUNSHINE PRODUCTS INC). PHOTRONICS INC runs the higher net margin — 10.9% vs 3.3%, a 7.6% gap on every dollar of revenue. On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs -5.5%). PHOTRONICS INC produced more free cash flow last quarter ($25.2M vs $7.6M). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs -3.8%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
Photronics, Inc. is an American semiconductor photomask manufacturer. It was the third largest photomask supplier globally as of 2009. Photronics is a member of the eBeam Initiative.
NATR vs PLAB — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $210.4M |
| Net Profit | $4.1M | $22.9M |
| Gross Margin | 72.5% | 33.7% |
| Operating Margin | 4.3% | 22.9% |
| Net Margin | 3.3% | 10.9% |
| Revenue YoY | 4.7% | -5.5% |
| Net Profit YoY | 1379.4% | -32.4% |
| EPS (diluted) | $0.23 | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | — | ||
| Q3 25 | $128.3M | $210.4M | ||
| Q2 25 | $114.8M | $211.0M | ||
| Q1 25 | $113.2M | $212.1M | ||
| Q4 24 | $118.2M | $222.6M | ||
| Q3 24 | $114.6M | $211.0M | ||
| Q2 24 | $110.6M | $217.0M | ||
| Q1 24 | $111.0M | $216.3M |
| Q4 25 | $4.1M | — | ||
| Q3 25 | $5.3M | $22.9M | ||
| Q2 25 | $5.3M | $8.9M | ||
| Q1 25 | $4.7M | $42.9M | ||
| Q4 24 | $-321.0K | $33.9M | ||
| Q3 24 | $4.3M | $34.4M | ||
| Q2 24 | $1.3M | $36.3M | ||
| Q1 24 | $2.3M | $26.2M |
| Q4 25 | 72.5% | — | ||
| Q3 25 | 73.3% | 33.7% | ||
| Q2 25 | 71.7% | 36.9% | ||
| Q1 25 | 72.1% | 35.6% | ||
| Q4 24 | 72.0% | 37.0% | ||
| Q3 24 | 71.3% | 35.6% | ||
| Q2 24 | 71.4% | 36.5% | ||
| Q1 24 | 71.2% | 36.6% |
| Q4 25 | 4.3% | — | ||
| Q3 25 | 7.0% | 22.9% | ||
| Q2 25 | 3.7% | 26.4% | ||
| Q1 25 | 5.4% | 24.6% | ||
| Q4 24 | 3.8% | 25.1% | ||
| Q3 24 | 4.6% | 24.7% | ||
| Q2 24 | 5.1% | 25.8% | ||
| Q1 24 | 4.2% | 26.6% |
| Q4 25 | 3.3% | — | ||
| Q3 25 | 4.2% | 10.9% | ||
| Q2 25 | 4.6% | 4.2% | ||
| Q1 25 | 4.2% | 20.2% | ||
| Q4 24 | -0.3% | 15.2% | ||
| Q3 24 | 3.8% | 16.3% | ||
| Q2 24 | 1.2% | 16.7% | ||
| Q1 24 | 2.1% | 12.1% |
| Q4 25 | $0.23 | — | ||
| Q3 25 | $0.30 | $0.39 | ||
| Q2 25 | $0.28 | $0.15 | ||
| Q1 25 | $0.25 | $0.68 | ||
| Q4 24 | $-0.02 | $0.54 | ||
| Q3 24 | $0.23 | $0.55 | ||
| Q2 24 | $0.07 | $0.58 | ||
| Q1 24 | $0.12 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $575.8M |
| Total DebtLower is stronger | — | $16.0K |
| Stockholders' EquityBook value | $161.6M | $1.1B |
| Total Assets | $261.1M | $1.8B |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | — | ||
| Q3 25 | $95.6M | $575.8M | ||
| Q2 25 | $81.3M | $558.4M | ||
| Q1 25 | $86.5M | $642.2M | ||
| Q4 24 | $84.7M | $640.7M | ||
| Q3 24 | $78.7M | $606.4M | ||
| Q2 24 | $68.7M | $559.9M | ||
| Q1 24 | $77.8M | $521.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $16.0K | ||
| Q2 25 | — | $19.0K | ||
| Q1 25 | — | $21.0K | ||
| Q4 24 | — | $25.0K | ||
| Q3 24 | — | $28.0K | ||
| Q2 24 | — | $2.5M | ||
| Q1 24 | $2.1M | $2.7M |
| Q4 25 | $161.6M | — | ||
| Q3 25 | $166.7M | $1.1B | ||
| Q2 25 | $163.7M | $1.1B | ||
| Q1 25 | $167.1M | $1.1B | ||
| Q4 24 | $161.0M | $1.1B | ||
| Q3 24 | $162.6M | $1.1B | ||
| Q2 24 | $156.4M | $1.0B | ||
| Q1 24 | $159.7M | $1.0B |
| Q4 25 | $261.1M | — | ||
| Q3 25 | $264.8M | $1.8B | ||
| Q2 25 | $254.9M | $1.7B | ||
| Q1 25 | $252.7M | $1.7B | ||
| Q4 24 | $240.9M | $1.7B | ||
| Q3 24 | $245.3M | $1.6B | ||
| Q2 24 | $235.8M | $1.6B | ||
| Q1 24 | $247.3M | $1.6B |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | 0.01× | 0.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $50.1M |
| Free Cash FlowOCF − Capex | $7.6M | $25.2M |
| FCF MarginFCF / Revenue | 6.1% | 12.0% |
| Capex IntensityCapex / Revenue | 1.9% | 11.8% |
| Cash ConversionOCF / Net Profit | 2.41× | 2.19× |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $64.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | — | ||
| Q3 25 | $18.5M | $50.1M | ||
| Q2 25 | $4.3M | $31.5M | ||
| Q1 25 | $2.6M | $78.5M | ||
| Q4 24 | $12.2M | $68.4M | ||
| Q3 24 | $9.6M | $75.1M | ||
| Q2 24 | $1.3M | $76.5M | ||
| Q1 24 | $2.2M | $41.5M |
| Q4 25 | $7.6M | — | ||
| Q3 25 | $16.8M | $25.2M | ||
| Q2 25 | $3.0M | $-29.1M | ||
| Q1 25 | $1.5M | $43.3M | ||
| Q4 24 | $10.0M | $25.2M | ||
| Q3 24 | $7.9M | $50.7M | ||
| Q2 24 | $-2.0M | $56.5M | ||
| Q1 24 | $-1.5M | $-1.8M |
| Q4 25 | 6.1% | — | ||
| Q3 25 | 13.1% | 12.0% | ||
| Q2 25 | 2.6% | -13.8% | ||
| Q1 25 | 1.3% | 20.4% | ||
| Q4 24 | 8.5% | 11.3% | ||
| Q3 24 | 6.9% | 24.0% | ||
| Q2 24 | -1.9% | 26.0% | ||
| Q1 24 | -1.4% | -0.8% |
| Q4 25 | 1.9% | — | ||
| Q3 25 | 1.3% | 11.8% | ||
| Q2 25 | 1.2% | 28.7% | ||
| Q1 25 | 1.0% | 16.6% | ||
| Q4 24 | 1.9% | 19.4% | ||
| Q3 24 | 1.5% | 11.6% | ||
| Q2 24 | 3.0% | 9.2% | ||
| Q1 24 | 3.3% | 20.0% |
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | 2.19× | ||
| Q2 25 | 0.81× | 3.55× | ||
| Q1 25 | 0.55× | 1.83× | ||
| Q4 24 | — | 2.02× | ||
| Q3 24 | 2.21× | 2.18× | ||
| Q2 24 | 0.97× | 2.11× | ||
| Q1 24 | 0.94× | 1.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
PLAB
| High End Integrated Circuits | $53.6M | 25% |
| High End Flat Panel Displays | $53.5M | 25% |
| KR | $43.7M | 21% |
| Other | $42.1M | 20% |
| Mainstream Flat Panel Displays | $9.1M | 4% |
| Transferred At Point In Time | $8.4M | 4% |
